BI drug named Promising Innovative Medicine in mesotheliomaBoehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for Share XBI drug named Promising Innovative Medicine in mesotheliomahttps://pharmaphorum.com/news/bi-drug-named-promising-innovative-medicine-mesothelioma/
